These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34900911)

  • 1. A Research on the Crisis Spillover Effect of Food Safety Incidents on Competitive Firms: The Influence of Political Connections and Charitable Donations.
    Xiang R; Wang M; Lin L; Wu D
    Front Public Health; 2021; 9():766385. PubMed ID: 34900911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will the "Environmental Fees to Taxes" Affect Firm Charitable Giving?
    Niu F; Wang J; Su W
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of food safety events on the value of food-related firms: An event study approach.
    Seo S; Jang SS; Miao L; Almanza B; Behnke C
    Int J Hosp Manag; 2013 Jun; 33():153-165. PubMed ID: 32287856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between Corporate Social Responsibility and Firm Value of Chinese Firms: Exploring from Degree of Internationalization.
    Wu R; Hossain MA; Teng Z; Shen X
    J Environ Public Health; 2023; 2023():7249799. PubMed ID: 36747500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
    Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
    PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can R&D investment reduce the impact of COVID-19 on firm performance?-Evidence from India.
    Biswas S
    J Public Aff; 2021 Oct; ():e2773. PubMed ID: 34899063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
    Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
    Front Psychol; 2021; 12():669715. PubMed ID: 35035363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
    Zhong M; Zhao W; Shahab Y
    Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking environmental corporate social responsibility to firm performance: The role of partnership restructure.
    Makhdoom ZH; Gao Y; Song X; Khoso WM; Baloch ZA
    Environ Sci Pollut Res Int; 2023 Apr; 30(16):48323-48338. PubMed ID: 36757592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How firms cope with social crisis: The mediating role of digital transformation as a strategic response to the COVID-19 pandemic.
    Wu W; Wang H; Lu L; Ma G; Gao X
    PLoS One; 2023; 18(4):e0282854. PubMed ID: 37014835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Market power in the United States red meatpacking industry.
    Koontz SR
    Vet Clin North Am Food Anim Pract; 2003 Jul; 19(2):519-44. PubMed ID: 12951745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do political incentives promote or inhibit corporate social responsibility? The role of local officials' tenure.
    Wu Y
    PLoS One; 2023; 18(3):e0283183. PubMed ID: 36930614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Product Market Competition and Firm Performance: Business Survival Through Innovation and Entrepreneurial Orientation Amid COVID-19 Financial Crisis.
    Liu Q; Qu X; Wang D; Abbas J; Mubeen R
    Front Psychol; 2021; 12():790923. PubMed ID: 35411208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The negative spillover effect of food crises on restaurant firms: Did Jack in the Box really recover from an
    Seo S; Jang SS; Almanza B; Miao L; Behnke C
    Int J Hosp Manag; 2014 May; 39():107-121. PubMed ID: 32287858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corporate philanthropy, political influence, and health policy.
    Fooks GJ; Gilmore AB
    PLoS One; 2013; 8(11):e80864. PubMed ID: 24312249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of corporate market power on health: exploring the structure-conduct-performance model from a public health perspective.
    Wood B; Williams O; Baker P; Nagarajan V; Sacks G
    Global Health; 2021 Apr; 17(1):41. PubMed ID: 33823900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China's Carbon Emissions and Trading Pilot, Political Connection, and Innovation Input of Publicly Listed Private Firms.
    Liu W; Yu C; Cheng S; Xu J; Wu Y
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of expected financial performance on corporate environmental responsibility disclosure: evidence from China.
    Zeng Y; Gulzar MA; Wang Z; Zhao X
    Environ Sci Pollut Res Int; 2020 Oct; 27(30):37946-37962. PubMed ID: 32613511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.
    Droppert H; Bennett S
    Global Health; 2015 Apr; 11():15. PubMed ID: 25886175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence in Asian Food Industry: Intellectual Capital, Corporate Financial Performance, and Corporate Social Responsibility.
    Tsai CH; Mutuc EB
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31968553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.